In this paper, we conclude that the reduction of SIRT1 molecular activity, on the one hand, leads to cell cycle arrest through p53/CDK2 signaling, and on the other hand, induces inflammation through the activation of NF-κB signaling pathway, both of which jointly promote aging and eventually form AAA. The gene discussed is TP53; the disease is triple-A syndrome.